(Q38218836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

EZH2: an emerging role in melanoma biology and strategies for targeted therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Peter Hersey

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

27 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

Pigment Cell & Melanoma Research

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

21-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24912396%20AND%20SRC:MED&resulttype=core&format=json

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

High-resolution profiling of histone methylations in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2 mutations are frequent and represent an early event in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Promiscuous RNA binding by Polycomb repressive complex 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Cancer epigenetics: from mechanism to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Targeting epigenetic readers in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Poly-combing the genome for RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Frequent mutation of BAP1 in metastasizing uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

PRC2 binds active promoters and contacts nascent RNAs in embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Deregulation of protein methylation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

BAP1 germline mutation in two first grade family members with uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Expression of polycomb group protein EZH2 in nevi and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Predicting deleterious amino acid substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The polycomb-group gene Ezh2 is required for early mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Inner workings and regulatory inputs that control Polycomb repressive complex 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Emerging epigenetic targets and therapies in cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Novel mutations target distinct subgroups of medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Interplay between the cancer genome and epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The INK4a/ARF network in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Roles of the EZH2 histone methyltransferase in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2: biology, disease, and structure-based drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Advances in targeting cell surface signalling molecules for immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Epigenetic regulation of skin: focus on the Polycomb complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280

Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12280